<unk>  is mainly used to treat chronic hepatitis B infection in adults and children two years and older with active viral replication and evidence of active disease with elevations in liver enzymes. It is also used to prevent HBV reinfection after liver transplant and to treat HIV patients infected with HBV.<unk>  is weakly active against HIV, but is not recommended for use in HIV-HBV co-infected patients without a fully suppressive anti-HIV regimen as it may select for resistance to lamivudine and emtricitabine in HIV. The efficacy of<unk>  has been studied in several randomized, double-blind, multicentre trials.<unk>  by mouth is effective and generally well tolerated treatment. Pregnancy and breastfeeding No adequate and well-controlled studies exist in pregnant women.
Entecavir
Saquinavir
Fosamprenavir
Coronavir
Abacavir
Indinavir
Fostemsavir
Tipranavir